Literature DB >> 16791471

Expression of SOX9 and SOX10 in central neuroepithelial tumor.

U Kordes1, C Hagel.   

Abstract

The SOX group E transcription factors play an integral role in the specification and differentiation of astrocytes and oligodendrocytes. We have examined the pattern of expression for SOX9 and SOX10 in primary brain tumors by immunohistochemistry. Pediatric and adult high grade tumors display strong nuclear staining for both SOX9 and SOX10 (astrocytic, oligodendroglial and primitive neuroectodermal tumors). In comparison pediatric pilocytic astrocytoma express much less SOX9 and SOX10. Reactive astrogliosis is characterized by an increase of SOX9 only.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16791471     DOI： 10.1007/s11060-006-9180-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  17 in total

1.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10.

Authors:  C Claus Stolt; Stephan Rehberg; Marius Ader; Petra Lommes; Dieter Riethmacher; Melitta Schachner; Udo Bartsch; Michael Wegner
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

2.  The Sox9 transcription factor determines glial fate choice in the developing spinal cord.

Authors:  C Claus Stolt; Petra Lommes; Elisabeth Sock; Marie-Christine Chaboissier; Andreas Schedl; Michael Wegner
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

Review 3.  From head to toes: the multiple facets of Sox proteins.

Authors:  M Wegner
Journal:  Nucleic Acids Res       Date:  1999-03-15       Impact factor: 16.971

4.  Impact of transcription factor Sox8 on oligodendrocyte specification in the mouse embryonic spinal cord.

Authors:  C Claus Stolt; Simone Schmitt; Petra Lommes; Elisabeth Sock; Michael Wegner
Journal:  Dev Biol       Date:  2005-05-15       Impact factor: 3.582

5.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

6.  Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signal.

Authors:  J W Mandell; N C Gocan; S R Vandenberg
Journal:  Glia       Date:  2001-06       Impact factor: 7.452

7.  Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.

Authors:  Timothy R Gershon; Orit Oppenheimer; Steven S Chin; William L Gerald
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

8.  Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.

Authors:  Fredrik K Johansson; Hanna Göransson; Bengt Westermark
Journal:  Oncogene       Date:  2005-06-02       Impact factor: 9.867

9.  Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.

Authors:  A J Janss; A T Yachnis; J H Silber; J Q Trojanowski; V M Lee; L N Sutton; G Perilongo; L B Rorke; P C Phillips
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

10.  Cancerous stem cells can arise from pediatric brain tumors.

Authors:  Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205
View more
  23 in total

1.  SOX9 induces and maintains neural stem cells.

Authors:  Charlotte E Scott; Sarah L Wynn; Abdul Sesay; Catarina Cruz; Martin Cheung; Maria-Victoria Gomez Gaviro; Sarah Booth; Bo Gao; Kathryn S E Cheah; Robin Lovell-Badge; James Briscoe
Journal:  Nat Neurosci       Date:  2010-10       Impact factor: 24.884

2.  Regrowth of transected retinal ganglion cell axons despite persistent astrogliosis in the lizard (Gallotia galloti).

Authors:  María del Mar Romero-Alemán; Maximina Monzón-Mayor; Elena Santos; Carmen M Yanes
Journal:  J Anat       Date:  2013-05-09       Impact factor: 2.610

3.  MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.

Authors:  Jian-Qiang Xu; Wei-Bin Zhang; Rong Wan; Yao-Qi Yang
Journal:  Tumour Biol       Date:  2014-07-03

4.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Authors:  Srinivas Malladi; Danilo G Macalinao; Xin Jin; Lan He; Harihar Basnet; Yilong Zou; Elisa de Stanchina; Joan Massagué
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

Review 5.  The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.

Authors:  Abby Sarkar; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

6.  ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.

Authors:  Changmeng Cai; Hongyun Wang; Housheng Hansen He; Sen Chen; Lingfeng He; Fen Ma; Lorelei Mucci; Qianben Wang; Christopher Fiore; Adam G Sowalsky; Massimo Loda; X Shirley Liu; Myles Brown; Steven P Balk; Xin Yuan
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

7.  Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.

Authors:  Gerard J Oakley; Kim Fuhrer; Raja R Seethala
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

8.  Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.

Authors:  Christian Hagel; András Treszl; Julia Fehlert; Jonas Harder; Franziska von Haxthausen; Meike Kern; André O von Bueren; Uwe Kordes
Journal:  J Neurooncol       Date:  2013-01-31       Impact factor: 4.130

9.  Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.

Authors:  Judith M de Bont; Johan M Kros; Monique M C J Passier; Roel E Reddingius; Peter A E Sillevis Smitt; Theo M Luider; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-06-24       Impact factor: 12.300

Review 10.  Role of SOX family of transcription factors in central nervous system tumors.

Authors:  Arlet M Acanda de la Rocha; Nicolas Sampron; Marta M Alonso; Ander Matheu
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.